OBJECTIVES To analyze and classify the Risk-Sharing Schemes (RSSs) proposed in reimbursement applications received by Agency for Health Technology Assessment in Poland (AHTAPol) in 2013. METHODS Risk-Sharing Schemes proposed in reimbursement applications received by AHTAPol in 2013 were quantitatively and qualitatively analyzed. The classification of the RSSs was conducted based on both Carlson’s approach and the Polish Act on the reimbursement of medicinal products. RESULTS In the studied period, 80 reimbursement applications for medicines, special purpose dietary supplements or medical devices were received by AHTAPol. Among them, there were 52 RSSs for 51, medical technologies. They were classified into 5 categories according to the Act on the reimbursement. The most common category was making the official sales price dependent on a pay-back of a part of the reimbursement obtained to the entity which is obliged to finance benefits with public funds (48.08%). Further categories were: making the official sales price dependent on the applicant providing supplies at a reduced price as specified in the negotiations on the price of the medicine (15.38%), making the official sales price dependent on the level of turnover of the medicine (11.54%) and making the level of the applicant’s revenues dependent on the health effects achieved (1.92%). Other, nonclassified RSSs constituted 23.08% of all. Among 52 proposed RSSs only 17 of them could be classified according to the Carlson’s approach. As a results, 10 Price Volume Agreements, 6 Manufacturer funded treatment initiation and 1 Conditional treatment continuation were identified. CONCLUSIONS Most of the propositions are not considered to be RSS according to the Carlson’s approach. The most common propositions were related to pay-back of a part of the reimbursement obtained for each reimbursed package and did not included any risk sharing. There is a strong need for further research.